Basic Information
| LncRNA/CircRNA Name | HOXA-AS2 |
| Synonyms | NA |
| Region | GRCh38_7:27107777-27134302 |
| Ensemble | ENSG00000253552 |
| Refseq | NR_122069 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qRT-PCR |
| Sample | NSCLC tissues,NSCLC cell lines (A549, SPCA1,PC-9, and H1299) |
| Expression Pattern | up-regulated |
| Function Description | HOXA-AS2 could enhance the migration and invasion abilities of NSCLC by targeting miR-145-3p. |
| Pubmed ID | 32096154 |
| Year | 2020 |
| Title | Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer |
External Links
| Links for HOXA-AS2 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |